Immunovant
IMVT
#3280
Rank
HK$26.78 B
Marketcap
HK$157.69
Share price
1.40%
Change (1 day)
-36.87%
Change (1 year)

Earnings for Immunovant (IMVT)

Earnings in 2024 (TTM): -HK$3.16 Billion

According to Immunovant's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -HK$1.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunovant from 2019 to 2024

Annual earnings

Year Earnings Change
2024 -HK$3.15 Billion59.79%
2023 -HK$1.97 Billion32.6%
2022 -HK$1.49 Billion39.55%
2021 -HK$1.07 Billion37.3%
2020 -HK$0.78 Billion780.74%
2019 -HK$88.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.11 Billion-64.74%๐Ÿ‡บ๐Ÿ‡ธ USA